Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Marianne Rudolph Hansen has worked on the following 23 EPO patent applications which have been published in the last five years:

EP11802239

METHODS OF HYDROLYZING OLIGOMERS IN HEMICELLULOSIC LIQUOR

IPC classification:
C12N 9/42, C12P 19/02, D21C 1/00
Applicant:
Novozymes North America, Inc.
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12710413

METHODS OF INCREASING THE CELLULOLYTIC ENHANCING ACTIVITY OF A POLYPEPTIDE

IPC classification:
C07K 14/37, C12P 7/10, C12P 19/10
Applicant:
Novozymes A/S
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12765435

METHOD FOR DEGRADING OR CONVERTING CELLULOSIC MATERIAL

IPC classification:
C12N 9/08, C12N 9/42, C12N 15/53, C12N 15/56, C12S 3/04
Applicant:
Novozymes A/S
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12712209

CELLULOSE BINDING DOMAIN VARIANTS AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C12N 9/42
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12776771

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C07K 14/37, C12N 5/10, C12N 9/42, C12N 15/56, C12N 15/63, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12722962

METHODS FOR ENHANCING THE DEGRADATION OR CONVERSION OF CELLULOSIC MATERIAL

IPC classification:
C11D 3/386, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12723981

POLYPEPTIDES HAVING ENDOGLUCANASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
C12N 9/42
Applicant:
Novozymes A/S
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP12723068

METHODS FOR ENHANCING THE DEGRADATION OF CELLULOSIC MATERIAL WITH CHITIN BINDING PROTEINS

IPC classification:
C12P 7/10, C12P 19/02, C12P 19/04, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12723067

METHODS FOR ENHANCING THE DEGRADATION OF CELLULOSIC MATERIAL WITH CHITIN BINDING PROTEINS

IPC classification:
C12P 7/10, C12P 19/02, C12P 19/12, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
GRANT OF PATENT INTENDED
EP12749154

POLYPEPTIDES HAVING CELLULOLYTIC ENHANCING ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME

IPC classification:
A01H 1/00, C07K 14/37, C12N 9/42, C12N 15/56, C12N 15/63, C12P 19/00, C12P 19/14
Applicant:
Novozymes Inc
Agent:
Multiple attorneys, Novozymes A/S
Status:
EXAMINATION IN PROGRESS
EP13791808

OLIGONUCLEOTIDE CONJUGATES

IPC classification:
C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13794852

ANTI APOB ANTISENSE CONJUGATE COMPOUNDS

IPC classification:
A61P 3/06, C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13795243

COMPOSITIONS AND METHODS FOR MODULATION OF FGFR3 EXPRESSION

IPC classification:
A61K 31/7125, C07H 21/00, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14704307

LNA OLIGONUCLEOTIDE CARBOHYDRATE CONJUGATES

IPC classification:
A61K 31/712, C12N 15/113
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14726003

OLIGONUCLEOTIDE MODULATORS OF B-CELL CLL/LYMPHOMA 11A (BCL11A) AND USES THEREOF

IPC classification:
C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13163795

Purification process

IPC classification:
C07K 14/79
Applicant:
Novozymes Biopharma DK A/S
Agent:
Marianne Rudolph Hansen, Novozymes A/S
Agent:
Rachel Clare Williams, Novozymes Biopharma UK Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14739708

ANTISENSE OLIGOMERS AND CONJUGATES TARGETING PCSK9

IPC classification:
A61K 31/712, A61P 3/06, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Zacco Denmark A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14799402

APOB ANTISENSE CONJUGATE COMPOUNDS

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP16184264

SMALL MOLECULE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS

IPC classification:
A61K 31/713, A61K 47/18, A61K 48/00, C07H 21/02, C12N 15/11, C12N 15/87
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15778299

GALNAC PHOSPHORAMIDITES, NUCLEIC ACID CONJUGATES THEREOF AND THEIR USE

IPC classification:
C07H 15/04, C07H 15/08, C07H 21/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797652

LNA CHIRAL PHOSPHOROTHIOATES

IPC classification:
A61K 31/7125, C07H 21/00
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797651

LNA GAPMER OLIGONUCLEOTIDES COMPRISING CHIRAL PHOSPHOROTHIOATE LINKAGES

IPC classification:
A61K 31/712, A61K 31/7125, C07H 21/00
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15813345

CHIRAL TOXICITY SCREENING METHOD

IPC classification:
C12N 15/11, C12N 15/113
Agent:
Marianne Rudolph Hansen, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature